药物滥用检测市场规模、份额和成长分析(按产品、检体类型、应用、最终用户和地区划分)—产业预测(2026-2033 年)
市场调查报告书
商品编码
1915962

药物滥用检测市场规模、份额和成长分析(按产品、检体类型、应用、最终用户和地区划分)—产业预测(2026-2033 年)

Drugs Of Abuse Testing Market Size, Share, and Growth Analysis, By Product (Consumables, Equipment), By Sample Type (Saliva, Urine), By Application, By End User, By Region - Industry Forecast 2026-2033.

出版日期: | 出版商: SkyQuest | 英文 181 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球药物滥用检测市场规模预计在 2024 年达到 68 亿美元,从 2025 年的 69 亿美元增长到 2033 年的 77.8 亿美元,在预测期(2026-2033 年)内复合年增长率为 1.5%。

全球药物滥用检测市场预计将迎来显着成长,这主要得益于企业健康检查的日益普及和药物滥用发生率的上升。人们对药物滥用障碍的认识不断提高以及监管的日益严格,正在推动市场创新。药物相关死亡人数的增加凸显了对可靠检测方法的迫切需求,从而推动了公共和医疗保健领域对先进解决方案的需求。关键趋势包括向就地检验和快速检测的转变,这些方法能够提供更高的准确性和速度,尤其是在路边和职场环境中。穿戴式装置和非侵入性检测方法(例如唾液和汗液分析)等技术进步也正在广泛应用。然而,开发中国家意识不足、检测设备高成本以及严格的监管等挑战可能会减缓市场扩张。

全球药物滥用检测市场驱动因素

技术创新推动了高精度检测设备的研发,显着促进了全球药物滥用检测市场的成长。随着生活水准的提高,成年人对药物滥用检测的需求日益增长。政府机构和私人企业积极倡导预防措施,以遏止成年人药物滥用,进一步推动了这一趋势。先进技术与社会压力之间的协同作用,正在巩固药物检测解决方案的基础,并推动市场动态。

限制全球药物滥用检测市场的因素

成本和可负担性是全球药物滥用检测市场渗透的重大挑战。许多中小企业和医疗机构发现,全面的检测项目费用高昂,难以负担,限制了产业发展机会。此外,市场也担忧检测结果被篡改和规避,因为个人常常会采取一些会降低检测准确性的方法(例如使用合成尿液或各种掩蔽剂来规避检测)。这些问题不仅会降低检测程序的可靠性,还会阻碍整个产业的发展,从而阻碍其更广泛的应用和实施。

全球药物滥用检测市场趋势

全球药物滥用检测市场正经历着向非侵入性检测技术的显着转变,这主要得益于人们对更便利、更安全、更非侵入性采样方法的需求。汗液、毛髮和唾液等检体采集方法因其操作简单、污染风险低、隐私顾虑少等优点,正日益受到青睐,远胜于传统的血液和尿液检查等方法。这些创新技术不仅延长了检测窗口期,尤其有利于检测慢性药物滥用,而且已被广泛应用于路边检测、康復机构和职场药物检测等各种场景,代表着该行业的变革性趋势。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 一手和二手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2025)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 用例
  • 顾客购买行为分析

全球药物滥用检测市场规模(按产品和复合年增长率划分)(2026-2033 年)

  • 消耗品
  • 装置
  • 快速检测装置
  • 服务

全球药物滥用检测市场规模(按检体类型和复合年增长率划分)(2026-2033 年)

  • 唾液
  • 尿
  • 头髮
  • 吐气

全球药物滥用检测市场规模(按应用领域及复合年增长率划分)(2026-2033 年)

  • 筛检
  • 疼痛管理监测
  • 法医学/法律资讯
  • 就业药物检测
  • 体育比赛测试

全球药物滥用检测市场规模(依最终用户划分)及复合年增长率(2026-2033 年)

  • 医院
  • 法医学实验室
  • 诊断中心
  • 专科诊所

全球药物滥用检测市场规模及复合年增长率(2026-2033)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • GCC
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2025 年)

主要企业简介

  • Quest Diagnostics Incorporated
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Quidel Corporation
  • Express Diagnostics International Inc.
  • Blue Origin
  • Thermo Fisher Scientific, Inc
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Laboratory Corporation of America Holdings
  • Clinical Reference Laboratory, Inc.
  • Cordant Health Solutions
  • Merck KGaA

结论与建议

简介目录
Product Code: SQMIG35J2146

Global Drugs Of Abuse Testing Market size was valued at USD 6.8 Billion in 2024 and is poised to grow from USD 6.9 Billion in 2025 to USD 7.78 Billion by 2033, growing at a CAGR of 1.5% during the forecast period (2026-2033).

The global drugs of abuse testing market is poised for significant growth, driven by an increasing trend in employment medical screenings and the rising incidence of substance use. Growing awareness of substance use disorders and stringent regulations are propelling market innovation. The urgent need for reliable testing methods, highlighted by rising drug-related fatalities, spurs demand for advanced solutions in public safety and healthcare. Key trends include a shift towards point-of-care and rapid testing, enhancing accuracy and timeliness, particularly in roadside and workplace scenarios. Technological advancements, like wearable devices and non-invasive testing methods, such as saliva and sweat analysis, are gaining traction. Nonetheless, challenges such as limited awareness in developing countries, high costs of testing devices, and stringent regulations may slow market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drugs Of Abuse Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drugs Of Abuse Testing Market Segments Analysis

Global Drugs Of Abuse Testing Market is segmented by Product, Sample Type, Application, End User and region. Based on Product, the market is segmented into Consumables, Equipment, Rapid Testing Devices and Services. Based on Sample Type, the market is segmented into Saliva, Urine, Hair, Breath, Blood and Sweat. Based on Application, the market is segmented into Medical Screening, Monitoring Pain Management, Forensic & Legal Information, Employment Drug Testing and Sports & Athletics Testing. Based on End User, the market is segmented into Hospital, Forensic Labs, Diagnostic Centres and Speciality Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drugs Of Abuse Testing Market

Technological advancements have led to the creation of highly precise and accurate testing instruments, significantly driving the growth of the Global Drugs of Abuse Testing market. As living standards continue to rise, there is an increasing necessity for adults to undergo drug abuse testing. This trend is further supported by initiatives from both government agencies and private enterprises that advocate for drug of abuse testing as a proactive measure to combat drug misuse among adults. The combined influence of advanced technology and societal pressures is fostering a more robust landscape for drug testing solutions, thereby enhancing market dynamics.

Restraints in the Global Drugs Of Abuse Testing Market

Cost and affordability present significant challenges for the penetration of the global drugs of abuse testing market. Many small companies and healthcare providers find comprehensive testing programs prohibitively expensive, which limits the industry's growth opportunities. Additionally, the market faces concerns related to adulteration and evasion tactics, as individuals often resort to strategies that compromise the accuracy of screening methods, such as using synthetic urine or various masking agents to pass tests. These issues not only undermine the reliability of testing procedures but also hinder the overall advancement of the sector, creating barriers for wider adoption and implementation.

Market Trends of the Global Drugs Of Abuse Testing Market

The Global Drugs of Abuse Testing market is witnessing a significant shift towards non-invasive testing techniques, driven by the demand for simpler, safer, and less intrusive sampling methods. Collection of samples such as sweat, hair, and saliva is gaining popularity due to their ease of use, reduced risk of contamination, and minimal privacy concerns compared to traditional methods like blood and urine tests. These innovative techniques not only extend detection windows, particularly beneficial for chronic use, but are also being increasingly adopted in diverse applications such as roadside testing, rehabilitation centers, and workplace drug testing, indicating a transformative trend in the industry.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Customer Buying Behavior Analysis

Global Drugs Of Abuse Testing Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Consumables
  • Equipment
  • Rapid Testing Devices
  • Services

Global Drugs Of Abuse Testing Market Size by Sample Type & CAGR (2026-2033)

  • Market Overview
  • Saliva
  • Urine
  • Hair
  • Breath
  • Blood
  • Sweat

Global Drugs Of Abuse Testing Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Medical Screening
  • Monitoring Pain Management
  • Forensic & Legal Information
  • Employment Drug Testing
  • Sports & Athletics Testing

Global Drugs Of Abuse Testing Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospital
  • Forensic Labs
  • Diagnostic Centres
  • Speciality Clinics

Global Drugs Of Abuse Testing Market Size & CAGR (2026-2033)

  • North America (Product, Sample Type, Application, End User)
    • US
    • Canada
  • Europe (Product, Sample Type, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Sample Type, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Sample Type, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Sample Type, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025

Key Company Profiles

  • Quest Diagnostics Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quidel Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Express Diagnostics International Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Blue Origin
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific, Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthcare GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Laboratory Corporation of America Holdings
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Clinical Reference Laboratory, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cordant Health Solutions
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations